NSEStatement of deviation(s) or variation(s) under Reg. 3213 Aug 2026 · 13 Aug 2026, 12:54 pm

Statement of deviation(s) or variation(s) under Reg. 32

Finkurve Financial Services Limited · FINKURVE

✦ AI SummaryFundraise

Finkurve Financial Services Limited has informed the Exchange about a statement of deviation(s) or variation(s) under Reg. 32, stating that the proceeds of the issue of Preferential Issue of Equity Shares and Share Warrants on private placement basis were used for the stated purpose and there is no material deviation in use of proceeds from the objects stated in the offer document.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Finkurve Financial Services Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32

Attachments (1)

📄

FINKURVE_13082026125446_Covering_Letter_Statement_of_Deviation.pdf

pdf

Download →
View document text
August 13, 2026 To, To, Listing Department The Manager – Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Dalal Street, ‘Exchange Plaza’ Bandra Kurla Complex, Mumbai – 400 001 Bandra (East) Mumbai 400051 Scrip Code: NSE Symbol: FINKURVE Equity: 508954 Subject: Declaration in respect of Regulation 32(1) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 Dear Sir/Madam, Pursuant to Regulation 32(1) of the SEBI (LODR) Regulations, 2015 we hereby declare that the proceeds of the issue of Preferential Issue of Equity Shares and Share Warrants on private placement basis issued by the Company during the Quarter ended June 30, 2026, were used for the purpose stated in the offer document and further there is no material deviation in use of proceeds of such issue from the objects stated in the offer document of the issue. The aforementioned statement in “Annexure 1” for the quarter ended June 30, 2026 is annexed herewith has been reviewed and noted by the Audit Committee at its Meeting held on August 13, 2026. You are requested to take note of the same. Thanking you For Finkurve Financial Services Limited Kajal Parmar Company Secretary & Compliance Officer Membership No: ACS65484 Encl: as above Annexure 1 Statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. Name of listed entity Finkurve Financial Services Limited Mode of Fund Raising Preferential Issue of Equity Shares and Share Warrant on Private Placement Basis Date of Raising Funds May 21, 2025 and May 27, 2025 Amount Raised Rs. 141.50 Crore Report filed for Quarter ended June 30, 2026 Monitoring Agency Applicable Monitoring Agency Name, if applicable CRISIL Rating Limited Is there a Deviation / Variation in use of funds No raised If yes, whether the same is pursuant to change - in terms of a contract or objects, which was approved by the shareholders If Yes, Date of shareholder Approval - Explanation for the Deviation / Variation - Comments of the Audit Committee after review - Comments of the auditors, if any - Objects for which funds have been raised and Not Applicable where there has been a deviation, in the following table Original Modified Original Modified Funds Amount of Remarks if any Object Object, if Allocation allocation, if Utilised Deviation/ any (Rs. In any (Rs. In Variation for Crore) Crore) the quarter according to applicable object Onward NA 141.50 NA 111.50 NA NA lending and (Rs. 30cr investment Being 75% and of the share repayment warrants of subscription borrowing amount yet obtained to be by received) company in ordinary course of business Deviation or variation could mean: (a) Deviation in the objects or purposes for which the funds have been raised or (b) Deviation in the amount of funds actually utilized as against what was originally disclosed or (c) Change in terms of a contract referred to in the fund raising document i.e. prospectus, letter of offer, etc.